Ads
related to: hormone replacement therapy prostate cancer- Dosing & Administration
Once-A-Day Treatment For
Advanced Prostate Cancer
- View Dosing FAQs
HCPs: Learn About A
Once-Daily Treatment Option
- Dosing Information
Find Dosing Info For An
APC Treatment Option
- Dosing Card
Download The Dosing Card
& More Rx Info Here
- Dosing & Administration
Search results
Results From The WOW.Com Content Network
Radiation therapy is often used in conjunction with hormone therapy for high-risk patients. [27] For men over 64 with prostate cancer limited to the pelvis, using fewer, larger doses of radiation (hypofractionation) results in similar overall survival rates. [28]
Polyestradiol phosphate (PEP), sold under the brand name Estradurin, is an estrogen medication which is used primarily in the treatment of prostate cancer in men. [1] [9] [2] [10] It is also used in women to treat breast cancer, as a component of hormone therapy to treat low estrogen levels and menopausal symptoms, and as a component of feminizing hormone therapy for transgender women.
The estrogen diethylstilbestrol (DES) is occasionally used to treat prostate cancer through suppression of testosterone production. It was previously used in the treatment of breast cancer, but has been replaced by more effective and less toxic agents. Estrace is an estrogen which was also formerly used for antiandrogen therapy of prostate ...
Androgen deprivation therapy (ADT), also called androgen ablation therapy or androgen suppression therapy, is an antihormone therapy whose main use is in treating prostate cancer. Prostate cancer cells usually require androgen hormones, such as testosterone, to grow. ADT reduces the levels of androgen hormones, with drugs or surgery, to prevent ...
Bicalutamide is used primarily in the treatment of early and advanced prostate cancer. [1] It is approved at a dosage of 50 mg/day as a combination therapy with a gonadotropin-releasing hormone analogue (GnRH analogue) or orchiectomy (that is, surgical or medical castration) in the treatment of stage D2 metastatic prostate cancer (mPC), [2] [3] and as a monotherapy at a dosage of 150 mg/day ...
HDE and pseudopregnancy have been used in medicine for a number of hormone-dependent indications, such as breast cancer, prostate cancer, and endometriosis, among others. [1] [7] [2] Both natural or bioidentical estrogens and synthetic estrogens have been used and both oral and parenteral routes may be used. [8] [9]
Ads
related to: hormone replacement therapy prostate cancer